Shanghai Junshi Biosciences Co., Ltd. (“the Company,” HKEX: 1877), an innovation-driven biopharmaceutical company dedicated to the discovery and development of innovative drugs with clinical research and commercialization on a global scale, today reported key financial results for the year 2019.
March 2, 2020
· 3 min read